Patient and physician satisfaction with proton pump inhibitors (PPIs): Are there opportunities for improvement?

Digestive Diseases and Sciences

Volumn 55, Issue 12, 2010, Pages 3415-3422

  Chey, William D ^b   Mody, Reema R ^a   Izat, Esin ^a  

^a Takeda Pharmaceuticals International Inc   (United States)

^b NONE

Author keywords

GERD; Patient satisfaction; Physician satisfaction; Proton pump inhibitors; Reflux

Indexed keywords

BICARBONATE; ESOMEPRAZOLE; LANSOPRAZOLE; NON PRESCRIPTION DRUG; OMEPRAZOLE; PANTOPRAZOLE; PRESCRIPTION DRUG; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; AGED; ARTICLE; DRUG COST; DRUG SAFETY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; PATIENT SATISFACTION; PHYSICIAN SATISFACTION; PRIORITY JOURNAL; SATISFACTION; SYMPTOMATOLOGY; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROTON PUMP INHIBITORS; TREATMENT OUTCOME;

EID: 78649315933     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1209-2     Document Type: Article

References (19)

1. RS Sandler JE Everhart M Donowitz, et al. 2002 The burden of selected digestive diseases in the United States Gastroenterology 122 1500 1511 10.1053/gast.2002.32978 11984534
2. D Armstrong 2008 Systematic review: persistence and severity in gastroesophageal reflux disease Aliment Pharmacol Ther 28 841 853 1:STN:280:DC%2BD1cnhsVGhsg%3D%3D 18637097
3. N Vakil 2004 Review article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease Aliment Pharmacol Ther 19 1041 1049 1:CAS:528:DC%2BD2cXlsVaju7g%3D 10.1111/j.1365-2036.2004.01957.x 15142193
4. C Calabrese A Fabbri G Di Febo 2007 Long-term management of GERD in the elderly with pantoprazole Clin Intery Aging 2 85 92 1:CAS:528: DC%2BD2sXmt12ku7o%3D 10.2147/ciia.2007.2.1.85
5. M Pettit 2005 Treatment of gastroesophageal reflux disease Pharm World Sci 27 432 435 10.1007/s11096-005-4798-7 16341949
6. V Becker M Bajbouj K Waller RM Schmid A Meining 2007 Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors-a follow-up study of intraluminal-impedance guided therapy Aliment Pharmacol Ther 26 1355 1360 1:CAS:528:DC%2BD1cXitlyg 10.1111/j.1365-2036.2007.03529.x 17900268
7. National Digestive Diseases Information Clearinghouse (NDDIC): Heartburn, gastroesophageal reflux (GER), and gastroesophageal reflux disease (GERD). Available at: http://digestive.niddk.nih.gov/ddiseases/pubs/gerd/. Accessed Aug 28, 2008.
8. H Liker P Hungin I Wiklund 2005 Managing gastroesophageal reflux disease in primary care: the patient perspective J Am Board Fam Pract 18 393 400 10.3122/jabfm.18.5.393 16148249
9. JF Bretagne C Honnohat B Richard-Mollard A Caekkaerts P Barthelemys 2006 Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms Aliment Pharmacol Ther 23 607 616 1:STN:280:DC%2BD28%2FpsVWmug%3D%3D 10.1111/j.1365-2036.2006.02811.x 16480400
10. M Kulig A Leodolter M Vieth, et al. 2003 Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-an analysis based on the ProGERD initiative Aliment Pharmacol Ther 18 767 776 1:STN:280: DC%2BD3sritlegsw%3D%3D 10.1046/j.1365-2036.2003.01770.x 14535869
11. P Wahlqvist M Karlsson D Johnson J Carlsson SC Bolge MA Wallander 2008 Relationship between symptom load of gastro-esophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort Aliment Pharmacol Ther 27 960 970 1:STN:280:DC%2BD1c3lsFeqsQ%3D%3D 10.1111/j.1365-2036.2008.03671.x 18315585
12. JA Crawley CM Schmitt 2000 How satisfied are chronic heartburn sufferers with their prescription medications? Results of the patient unmet needs survey J Clin Outcomes Manag 7 29 34
13. C Donnellan N Sharma C Preston P Moayyedi 2004 Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease Cochrane Database Syst Rev 2 CD003245
14. M Robinson K Shaw 2002 Proton pump inhibitor attitudes and usage: A patient survey Pharm Ther 27 202 206
15. JG Hatlebakk PO Katz L Camacho-Lobato DO Castell 2000 Proton pump inhibitors: better acid suppression when taken before a meal than without a meal Aliment Pharmacol Ther 14 1267 1272 1:CAS:528:DC%2BD3cXotV2jsbo%3D 10.1046/j.1365-2036.2000.00829.x 11012470
16. R Hunt Y Yuan M Yaghoobi 2007 GERD: new strategies and new failures J Clin Gastroenterol 41 Supp 2 S72 S80 10.1097/MCG.0b013e31803238d6
17. I Mainie R Tutuian S Shay, et al. 2006 Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring Gut 55 1398 1402 1:CAS:528:DC%2BD28XhtFeht7zI 10.1136/gut.2005.087668 16556669
18. JH Rubenstein B Nojkov S Korsnes, et al. 2007 Esophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome Aliment Pharmacol Ther 26 443 452 1:STN:280:DC%2BD2svhvVOhug%3D%3D 10.1111/j.1365-2036.2007.03393.x 17635379
19. B Nojkov R Saad S Adlis M Shaw WD Chey 2008 Predictors of response to PPI therapy in patients with GERD: the influence of co-morbid IBS and psychological disease Aliment Pharmacol Ther 27 473 482 1:CAS:528:DC%2BD1cXksFSks78%3D 10.1111/j.1365-2036.2008.03596.x 18194508